ObsEva announces new composition of its Executive Committee
Geneva, Switzerland and Boston, MA – September 11, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy, announce today changes to the composition of its Executive Committee following approval by its Board of Directors
Effective today, the following members of ObsEva’s Executive Committee are:
- Ernest Loumaye, Chief Executive Officer and Co-Founder
- Tim Adams, Chief Financial Officer
- Elizabeth Garner, Chief Medical Officer
- Jean-Pierre Gotteland, Chief Scientific Officer and Head of Research and Development
- Wim Souverijns, Chief Commercial Officer
Elke Bestel, Vice-President, Head of Drug Safety and Pharmacovigilance, Ben Tan, Vice-President Commercial and Business Development and Fabien de Ladonchamps, Vice-President Corporate Affairs and Finance step down from the Executive Committee with immediate effect, but remain members of the company’s senior management.
Ernest Loumaye, CEO and Co-Founder of ObsEva said: “With the hiring of Wim Souverijns and Elizabeth Garner, the Board believes that it now has an Executive Committee with all the required talents the company needs to steer it through its important upcoming milestones. We would like to warmly thank the talented outgoing members of the management team, for their excellent contribution to the Executive Committee to date”.
ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids, preterm labor and improving IVF outcomes. ObsEva is listed on The NASDAQ Global Select Market and is trading under the ticker symbol "OBSV", as well as on the SIX Swiss Exchange where it is trading under the ticker symbol “OBSN”.
For more information, please visit www.ObsEva.com.
Cautionary Note Regarding Forward Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as "believe", "expect", "may", "plan," "potential," "will," and similar expressions, and are based on ObsEva’s current beliefs and expectations. These forward-looking statements include expectations regarding the clinical development of ObsEva’s product candidates. These statements involve risks and uncertainties that could cause actual results to differ materially from those reflected in such statements. Risks and uncertainties that may cause actual results to differ materially include uncertainties inherent in the conduct of clinical trials, clinical development and related interactions with regulators, ObsEva’s reliance on third parties over which it may not always have full control, and other risks and uncertainties that are described in the Risk Factors section of ObsEva’s Annual Report on Form 20-F for the year ended December 31, 2018, and other filings ObsEva makes with the SEC. These documents are available on the Investors page of ObsEva’s website at http://www.obseva.com . Any forward-looking statements speak only as of the date of this press release and are based on information available to ObsEva as of the date of this release, and ObsEva assumes no obligation to, and does not intend to, update any forward-looking statements, whether as a result of new information, future events or otherwise.
This is not an offer of securities for sale in the United States. Securities may not be offered or sold in the United States unless they are registered or exempt from registration. Any public offering of securities in the United States, if any, will be made by means of a prospectus that may be obtained from the Company and that will contain detailed information about the Company and management as well as financial statements.
This material does not constitute or contain any offer to sell or invitation to subscribe or make commitments for or in respect of any security in any jurisdiction. There may be restrictions on the distribution of this material in certain jurisdictions, including Canada, Australia, Japan and the member states of the European Economic Area and the United Kingdom of Great Britain and Northern Ireland. Persons into whose possession this material may come are required to inform themselves of and observe any such restrictions.
For further information, please contact:
Media Contact Switzerland and Europe:
+41 22 308 6220 Office
+41 79 476 26 87 Mobile
Media Contact U.S.:
+1 212 223 4047 Office
+1 646 537 5649 Mobile
CEO Office Contact:
+41 22 552 1550
Senior Director, Investor Relations
+1 857 972 9347 Office
+1 781 366 5726 Mobile
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Mandalay Resources Corporation tillkännager produktions- och försäljningsresultat för fjärde kvartalet och helåret 2019 samt produktions- och kostnadsprognos för 202018.1.2020 13:30:00 CET | Pressemelding
TORONTO, Jan. 18, 2020 (GLOBE NEWSWIRE) -- Mandalay Resources Corporation (”Mandalay” eller ”bolaget”) (TSX: MND, OTCQB: MNDJF) tillkännagav idag sina produktions- och försäljningsresultat för fjärde kvartalet och helåret 2019. Under fjärde kvartalet 2019 producerade Mandalay en konsoliderad mängd motsvarande 18 594 säljbara uns guldekvivalent och sålde 16 228 uns guldekvivalent. För helåret som slutade den 31 december 2019 producerade Mandalay 76 659 säljbara uns guldekvivalent och sålde 77 043 uns guldekvivalent. Dominic Duffy, President och Chief Executive Officer för Mandalay, kommenterar, ”Mandalays konsoliderade produktion för helåret 2019 motsvarade den reviderade prognosen som tillkännagavs i oktober 2019 för guld, antimon och guldekvivalenta uns. Björkdal fortsatte sin stabila drift under fjärde kvartalet med en produktion på 10 990 uns säljbart guld och 51 498 uns säljbart guld för helåret, en ungefärlig ökning på 12 % sedan samma period året innan. Vid Costerfield var result
Conditions for Riksbank Bid Procedures Sek Bonds17.1.2020 16:20:00 CET | Press release
Sveriges Riksbank Bid procedure details Government Bonds, 2020-01-23 Maturity date Loan ISIN code Coupon Volume, SEK million 2025-05-12 1058 SE0005676608 2.50 % 500 +/- 250 2028-05-12 1060 SE0009496367 0.75 % 500 +/- 250 Settlement date 2020-01-27 Bids have to be entered by 10.00 on JAN 23, 2020 Highest permitted bid volume: 500 SEK million in issue SGB 1058 and 500 SEK million in issue SGB 1060 Lowest permitted bid volume: 50 SEK million Bids only through counterparties approved by the Riksbank RESULT OF AUCTION WILL BE PUBLISHED NO LATER THAN 10.10 (CET) ON JAN 23, 2020. For more information, please contact: Trading desk at the Riksbank + 46 8 696 6970 General and special terms and conditions can be retrieved at http://www.riksbank.se
The Board of Directors of Cramo Plc supplements its statement regarding the recommended voluntary public cash tender offer by Boels Topholding B.V. due to the increase in the Offer Price17.1.2020 15:30:00 CET | Press release
Cramo Plc Stock exchange release 17 January 2020 at 4.30 pm (EET) The Board of Directors of Cramo Plc supplements its statement regarding the recommended voluntary public cash tender offer by Boels Topholding B.V. due to the increase in the Offer Price NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR HONG KONG, OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. FOR FURTHER INFORMATION, SEE SECTION "IMPORTANT LEGAL INFORMATION" BELOW. On 11 November 2019, Boels Topholding B.V. (the "Offeror" or "Boels") announced that it will make a recommended voluntary public cash tender offer to acquire all of the issued and outstanding shares in Cramo Plc ("Cramo") that are not held by Cramo or any of its subsidiaries (the "Shares") (the "Tender Offer"). The Board of Directors of Cramo (the "Cramo Board") has on 20 November 2019 issued a statement (the "Statement"
CrossAmerica Partners to Announce Year-End/Fourth Quarter 2019 Earnings Results on February 2517.1.2020 12:45:00 CET | Press release
Allentown, Jan. 17, 2020 (GLOBE NEWSWIRE) -- CrossAmerica Partners to Announce Year-End/Fourth Quarter 2019 Earnings Results on February 25 ALLENTOWN, PA, January 17, 2020 – CrossAmerica Partners LP (NYSE: CAPL) today announced that it will release its year-end/fourth quarter 2019 results after the market closes on Tuesday, February 25, 2020. In conjunction with the news release, management will host a conference call on Wednesday, February 26, at 9:00 a.m. Eastern Time. The conference call numbers are 877-420-2982 or 847-619-6129 and the passcode for both is 5577665#. A live audio webcast of the conference call and the related earnings materials, including reconciliations of any non-GAAP financial measures to GAAP financial measures and any other applicable disclosures, will be available on that same day on the investor section of the CrossAmerica website (www.crossamericapartners.com). To listen to the audio webcast, go to https://caplp.gcs-web.com/webcasts-presentations. After the l
Volta Finance Limited - Update Statement regarding AGM voting17.1.2020 11:38:00 CET | Press release
17 January 2020 Volta Finance Limited (VTA / VTAS) Update Statement regarding AGM voting Information disclosed in accordance with provision 1.D.4 of the 2018 UK Code of Corporate Governance and principle 5.2.4 of the 2019 AIC Code of Corporate Governance. Volta Finance Limited (the “Company”) announced “Results of the Thirteenth Annual General Meeting” on 6 December 2019 and noted the votes against the resolutions to approve the re-election of the directors, Graham Harrison, Stephen Le Page, Paul Meader, Atosa Moini and Paul Varotsis, contained in resolutions 4 to 8 inclusively. The votes against each resolution equated to 37.05% of the total voted by proxy. The Board, through the Company’s corporate broker, has sought to engage with the dissenting shareholders to understand their concerns. Unfortunately, despite multiple efforts, the Board and its adviser have been unsuccessful to date in gaining any response. The Board invites the dissenting shareholders to engage, either directly th
14 nya butiker – stark tillväxt i Elon Ljud & Bild17.1.2020 10:00:00 CET | Pressemelding
Under januari har 14 nya butiker anslutit sig till hemelektronikkedjan Elon Ljud & Bild. Kedjan består nu av över 100 butiker runt om i Sverige. ”Vi ser med stor tillförsikt och glädje att vi attraherar och tillför Elon Ljud & Bild nya lokala aktörer till kedjan”, säger Anneli Sjöstedt, VD på Electra. I november 2019 bytte närmare 100 Audio Video-butiker varumärke och bildade Elon Ljud & Bild. Nu vill fler butiker ansluta sig till hemelektronikkedjan. Vid årsskiftet tecknade 14 nya butiker, spridda över hela landet, avtal med Elon Ljud & Bild. De nya medlemsbutikerna kommer från konkurrerande kedjor eller är befintliga Elon butiker som utvidgar sitt koncept med Elon Ljud & Bild. Butikerna blir på så sätt en komplett leverantör av hemelektronik och vitvaror på sina lokala orter. - Vårt koncept ger kunden full handlingsfrihet utifrån sin egen situation och sina behov, vilket vi vet kommer att vara helt avgörande för en positiv köpupplevelse och långsiktig kundnöjdhet. Det känns som en na